Vanguard Group Inc. Cuts Position in National Research Co. (NASDAQ:NRC)

Vanguard Group Inc. trimmed its holdings in shares of National Research Co. (NASDAQ:NRC - Free Report) by 3.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 952,664 shares of the company's stock after selling 33,706 shares during the quarter. Vanguard Group Inc. owned 4.06% of National Research worth $16,805,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Geode Capital Management LLC grew its stake in National Research by 3.2% in the 3rd quarter. Geode Capital Management LLC now owns 420,733 shares of the company's stock worth $9,619,000 after buying an additional 13,039 shares in the last quarter. State Street Corp increased its stake in National Research by 4.0% in the third quarter. State Street Corp now owns 363,438 shares of the company's stock valued at $8,351,000 after acquiring an additional 14,144 shares during the last quarter. QV Investors Inc. raised its position in National Research by 4.5% during the fourth quarter. QV Investors Inc. now owns 354,360 shares of the company's stock valued at $6,251,000 after purchasing an additional 15,370 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in National Research by 88.5% during the fourth quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company's stock worth $3,832,000 after purchasing an additional 101,957 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of National Research by 0.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 124,711 shares of the company's stock worth $2,200,000 after purchasing an additional 970 shares in the last quarter. 47.26% of the stock is currently owned by institutional investors.

National Research Trading Down 3.5 %

Shares of NRC opened at $10.53 on Thursday. National Research Co. has a fifty-two week low of $10.45 and a fifty-two week high of $35.84. The firm has a market cap of $241.62 million, a price-to-earnings ratio of 10.03 and a beta of 0.41. The firm has a 50 day moving average price of $14.31 and a 200-day moving average price of $17.04. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47.

National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings results on Monday, January 27th. The company reported $0.28 earnings per share (EPS) for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

National Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were given a $0.12 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.48 annualized dividend and a yield of 4.56%. National Research's dividend payout ratio (DPR) is presently 45.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.